Neurones SA
PAR:NRO
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
40.25
47.55
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Neurones SA
Neurones SA
Accounts Receivables
Neurones SA
Accounts Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accounts Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Neurones SA
PAR:NRO
|
Accounts Receivables
€178.5m
|
CAGR 3-Years
12%
|
CAGR 5-Years
6%
|
CAGR 10-Years
7%
|
|
|
Sopra Steria Group SA
PAR:SOP
|
Accounts Receivables
€1.4B
|
CAGR 3-Years
8%
|
CAGR 5-Years
3%
|
CAGR 10-Years
11%
|
|
|
Capgemini SE
PAR:CAP
|
Accounts Receivables
€5.3B
|
CAGR 3-Years
9%
|
CAGR 5-Years
9%
|
CAGR 10-Years
7%
|
|
|
Alten SA
PAR:ATE
|
Accounts Receivables
€1.3B
|
CAGR 3-Years
17%
|
CAGR 5-Years
10%
|
CAGR 10-Years
12%
|
|
|
Societe Pour l Informatique Industrielle SA
PAR:SII
|
Accounts Receivables
€286m
|
CAGR 3-Years
18%
|
CAGR 5-Years
9%
|
CAGR 10-Years
11%
|
|
|
Exclusive Networks SAS
PAR:EXN
|
Accounts Receivables
€1.3B
|
CAGR 3-Years
18%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
Neurones SA
Glance View
Neurones SA, a formidable player in the European IT services landscape, operates with a keen focus on providing a diverse array of technological solutions that help organizations adapt to evolving business environments. Founded in the late 1980s, this Paris-based enterprise has grown to encompass a network of subsidiaries, each specializing in various domains of information technology and digital transformation. By maintaining a robust and versatile portfolio, Neurones SA effectively caters to sectors spanning from banking and insurance to telecommunications, healthcare, and public administration. The company’s innovative approach is built on a delicate balance of software integration, IT infrastructure management, and consulting services, ensuring clients not only adapt to change efficiently but also gain a competitive edge in their respective industries. Revenue generation for Neurones SA primarily hinges on delivering consultancy and project services that tailor technological advancements to specific client needs. The firm thrives by offering bespoke solutions that leverage cloud computing, cybersecurity, big data analytics, and digital user experience enhancements. Often, these projects commence with an in-depth assessment of a client’s existing systems and business strategies, leading to the blueprinting of comprehensive IT roadmaps aimed at elevating operational efficiency. By executing such targeted services, Neurones SA not only fortifies client relationships but also secures long-term contracts and recurring revenue flows, thereby cementing its financial foundation and sustaining growth momentum in an ever-competitive marketplace.
See Also
What is Neurones SA's Accounts Receivables?
Accounts Receivables
178.5m
EUR
Based on the financial report for Jun 30, 2024, Neurones SA's Accounts Receivables amounts to 178.5m EUR.
What is Neurones SA's Accounts Receivables growth rate?
Accounts Receivables CAGR 10Y
7%
Over the last year, the Accounts Receivables growth was 14%. The average annual Accounts Receivables growth rates for Neurones SA have been 12% over the past three years , 6% over the past five years , and 7% over the past ten years .
You don't have any saved screeners yet
